Evidence map›Paper›PMID 37104203›Full record

ArticleToxins2023

Proteomic Analysis, Immuno-Specificity and Neutralization Efficacy of Pakistani Viper Antivenom (PVAV), a Bivalent Anti-Viperid Antivenom Produced in Pakistan.

Andy Shing Seng Lim, Kae Yi Tan, Naeem H Quraishi, Saud Farooque, Zahoor Ahmed Khoso, Kavi Ratanabanangkoon, Choo Hock Tan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Toxins, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Andy Shing Seng LimVenom Research and Toxicology Laboratory, Department of Pharmacology, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia.
Kae Yi TanProtein and Interactomics Laboratory, Department of Molecular Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia.ORCID 0000-0002-6938-7325
Naeem H QuraishiSnake Antivenom/Antirabies Serology Laboratory, Department of Community Medicine & Public Health Sciences, People's University of Medical and Health Sciences for Women, Nawabshah 67450, Pakistan.
Saud FarooqueSnake Antivenom/Antirabies Serology Laboratory, Department of Community Medicine & Public Health Sciences, People's University of Medical and Health Sciences for Women, Nawabshah 67450, Pakistan.ORCID 0009-0007-9230-7585
Zahoor Ahmed KhosoSnake Antivenom/Antirabies Serology Laboratory, Department of Community Medicine & Public Health Sciences, People's University of Medical and Health Sciences for Women, Nawabshah 67450, Pakistan.ORCID 0000-0002-5293-912X
Kavi RatanabanangkoonDepartment of Microbiology, Faculty of Science, Mahidol University, Bangkok 73170, Thailand.
Choo Hock TanVenom Research and Toxicology Laboratory, Department of Pharmacology, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia.ORCID 0000-0003-1416-077X
University of Malaya · MYMahidol University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Snakebite envenoming is a neglected tropical disease prevalent in South Asia. In Pakistan, antivenoms are commonly imported from India despite the controversy over their effectiveness. To solve the problem, the locals have developed the Pakistani Viper Antivenom (PVAV), raised against Sochurek's Saw-scaled Viper (

Indexed as

DaboiaSnake BitesViperidaeAnimalsAntiveninsPakistanProteomicsViper VenomsAntiveninsViper Venomsantibodyimmunoglobulinsnakebite envenoming

Identifiers

PMID37104203
PMCPMC10145215
OpenAlexW4362591577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.